CF patients await access to ‘game-changing’ drug Trikafta as it moves closer to approval

Cystic fibrosis (CF) affects 43-hundred people in Canada, including 130 in Saskatchewan. Most of them don’t have access to any life-changing gene modifier drugs/medications that are available in other countries. Many CF patients are hopeful a drug called Trikafta moves closer to being approved in Canada.

MANY CF PATIENTS ARE REMAINING OPTIMISTIC AS THE DRUG TRIKAFTA INCHES ITS WAY CLOSER TO BE APPROVED IN CANADA.

• CF patients await access to ‘game-changing’ drug Trikafta as it moves closer to approval